Novavax Inc (NVAX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.33B
Last updated: Nov 17, 2026 at 4:41 PM ET
Novavax Inc (NVAX) Stock Chart
Novavax (NVAX) has a latest price of $7.96 on Nov 17, 2026, 40.6% below its 52-week high of $13.39. Its price rose 14.2% over the past 12 months. The month-end price fell 66.8% over the 10 years through Oct 2026, a compound annual decline of 10.5%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $238.54 in Aug 2021 and its lowest $3.98 in Dec 2019, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart NVAX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for NVAX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 9.4%, and over 6 months it fell 10.6%. The month-end price rose 51.4% over the 3 years through Oct 2026, a compound annual rate of 14.8%.
| Period | Change |
|---|---|
| 1 month | -26.4% |
| 3 months | -9.4% |
| 6 months | -10.6% |
| 12 months | +14.2% |
| 12 months, with dividends | +14.2% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +51.4% | +14.8% |
| 5 years | -93.2% | -41.6% |
| 10 years | -66.8% | -10.5% |
Price by Year
Its best calendar year was 2020, when the price rose 2,701.8%, and its weakest was 2022, when it fell 92.8%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $10.08 | +50.0% |
| 2025 | $6.72 | -16.4% |
| 2024 | $8.04 | +67.5% |
| 2023 | $4.80 | -53.3% |
| 2022 | $10.28 | -92.8% |
| 2021 | $143.07 | +28.3% |
| 2020 | $111.51 | +2,701.8% |
| 2019 | $3.98 | -89.2% |
| 2018 | $36.80 | +48.4% |
| 2017 | $24.80 | -1.6% |
Trading Range
The price is 23.8% below its 50-day average of $10.45 and 14.6% below its 200-day average of $9.33.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $7.96 | |
| 52-week high | $13.39 | -40.6% |
| 52-week low | $6.20 | +28.4% |
| 50-day average | $10.45 | -23.8% |
| 200-day average | $9.33 | -14.6% |
Price Risk
Over 3 years, its largest fall from a peak was 74.1%.
| Measure | Value |
|---|---|
| 1-year beta | 2.10 |
| Largest fall, 1 year | -37.9% |
| Largest fall, 3 years | -74.1% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About NVAX
What is NVAX's 1-year price change?
Novavax's price rose 14.2% over the past 12 months. With dividends included, the 12-month total return was 14.2%.
What is NVAX's 5-year price change?
Novavax's month-end price fell 93.2% over the 5 years through Oct 2026, a compound annual decline of 41.6%. These figures leave out dividends.
What is NVAX's 52-week high and low?
Novavax's 52-week high is $13.39 and its 52-week low is $6.20. Its latest price of $7.96 on Nov 17, 2026 is 40.6% below the high.
What is NVAX's beta?
Novavax's 1-year beta against the S&P 500 is 2.10, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 37.9%.
Is the NVAX chart free?
Yes. Advanced Charting for NVAX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
NVAX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors